These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20803604)

  • 1. Effects of vessel geometric irregularity on dissolution test results.
    Gao Z; Ahadi S; Moore TW; Doub WH; Westenberger BJ; Buhse LF
    J Pharm Sci; 2011 Mar; 100(3):1093-101. PubMed ID: 20803604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vibration effects of lab equipment on dissolution testing with USP paddle method.
    Gao Z; Thies A; Doub W
    J Pharm Sci; 2010 Jan; 99(1):403-12. PubMed ID: 19544371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cause of high variability in drug dissolution testing and its impact on setting tolerances.
    Qureshi SA; Shabnam J
    Eur J Pharm Sci; 2001 Jan; 12(3):271-6. PubMed ID: 11113646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance.
    Deng G; Ashley AJ; Brown WE; Eaton JW; Hauck WW; Kikwai LC; Liddell MR; Manning RG; Munoz JM; Nithyanandan P; Glasgow MJ; Stippler E; Wahab SZ; Williams RL
    Pharm Res; 2008 May; 25(5):1100-9. PubMed ID: 18172581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic error associated with apparatus 2 of the USP dissolution test II: Effects of deviations in vessel curvature from that of a sphere.
    Cox DC; Wells CE; Furman WB; Savage TS; King AC
    J Pharm Sci; 1982 Apr; 71(4):395-9. PubMed ID: 7086644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of variability in dissolution testing with USP apparatus 2.
    Gao Z; Moore TW; Smith AP; Doub WH; Westenberger BJ
    J Pharm Sci; 2007 Jul; 96(7):1794-801. PubMed ID: 17252609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution of prednisone tablets in the presence of an arch-shaped fiber optic probe in a USP dissolution testing apparatus 2.
    Zhang Y; Bredael G; Armenante PM
    J Pharm Sci; 2013 Aug; 102(8):2718-29. PubMed ID: 23861178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of deaeration methods on dissolution testing in aqueous media: a study using a total dissolved gas pressure meter.
    Gao Z; Moore TW; Doub WH; Westenberger BJ; Buhse LF
    J Pharm Sci; 2006 Jul; 95(7):1606-13. PubMed ID: 16732563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical modeling of variables involved in dissolution testing.
    Gao Z
    J Pharm Sci; 2011 Nov; 100(11):4934-42. PubMed ID: 21702052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrodynamic investigation of USP dissolution test apparatus II.
    Bai G; Armenante PM; Plank RV; Gentzler M; Ford K; Harmon P
    J Pharm Sci; 2007 Sep; 96(9):2327-49. PubMed ID: 17573698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The random vibration effects on dissolution testing with USP apparatus 2.
    Gao Z; Moore TW; Buhse LF; Doub WH
    J Pharm Sci; 2009 Jan; 98(1):297-306. PubMed ID: 18399543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing new acceptance limits for dissolution performance verification of USPC apparatus 1 and 2 using USPC prednisone tablets reference standard.
    DeStefano AJ; Hauck WW; Stippler ES; Brown WE; Li C; Huang GG; Jones BJ; O'Hool K; Koch WF; Williams RL
    Pharm Res; 2011 Mar; 28(3):505-16. PubMed ID: 20953675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissolution of USP prednisone calibrator tablets: effects of stirring conditions and particle size distribution.
    Röst M; Quist PO
    J Pharm Biomed Anal; 2003 Apr; 31(6):1129-43. PubMed ID: 12667929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A crescent-shaped spindle for improved dissolution testing.
    Qureshi SA
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):55-65. PubMed ID: 20144452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D hydrodynamics and shear rates' variability in the United States Pharmacopeia Paddle Dissolution Apparatus.
    Ameur H; Bouzit M
    Int J Pharm; 2013 Aug; 452(1-2):42-51. PubMed ID: 23680733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the use of a 200 ml vessel suitable for dissolution of low dose drug products?
    Crail DJ; Tunis A; Dansereau R
    Int J Pharm; 2004 Jan; 269(1):203-9. PubMed ID: 14698592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic error associated with apparatus 2 of the USP dissolution test IV: effect of air dissolved in the dissolution medium.
    Cox DC; Furman WB; Page DP
    J Pharm Sci; 1983 Sep; 72(9):1061-4. PubMed ID: 6631694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-stage sequential statistical dissolution testing rules.
    Tsong Y; Shen M; Shah VP
    J Biopharm Stat; 2004 Aug; 14(3):757-79. PubMed ID: 15468763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic error associated with apparatus 2 of the USP dissolution test I: Effects of physical alignment of the dissolution apparatus.
    Cox DC; Furman WB
    J Pharm Sci; 1982 Apr; 71(4):451-2. PubMed ID: 7086657
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydrodynamic, mass transfer, and dissolution effects induced by tablet location during dissolution testing.
    Bai G; Armenante PM
    J Pharm Sci; 2009 Apr; 98(4):1511-31. PubMed ID: 18781589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.